Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180717040509N1Phase 3Completed
Phase 3, randomised, double-blind trial comparing Ondansetron, Metoclopramide and Placebo normal saline (3 arms). Primary endpoint: Severity of nausea. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180717040509N1.